These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 6283083)
21. Synthesis of 2-amino-2-deoxy-beta-D-arabinofuranosyl nucleosides. Sato A; Imai R; Nakamizo N; Hirata T Chem Pharm Bull (Tokyo); 1979 Mar; 27(3):821-3. PubMed ID: 554746 [No Abstract] [Full Text] [Related]
22. Inactivation and reactivation of intracellular S-adenosylhomocysteinase in the presence of nucleoside analogues in rat hepatocytes. Schanche JS; Schanche T; Ueland PM; Montgomery JA Cancer Res; 1984 Oct; 44(10):4297-302. PubMed ID: 6467191 [TBL] [Abstract][Full Text] [Related]
23. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 8. Molecular dissections of carbocyclic 3-deazaadenosine as inhibitors of S-adenosylhomocysteine hydrolase. Houston DM; Dolence EK; Keller BT; Patel-Thombre U; Borchardt RT J Med Chem; 1985 Apr; 28(4):467-71. PubMed ID: 3981538 [TBL] [Abstract][Full Text] [Related]
24. Incorporation of 9-beta-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA. Spriggs D; Robbins G; Mitchell T; Kufe D Biochem Pharmacol; 1986 Jan; 35(2):247-52. PubMed ID: 3942598 [TBL] [Abstract][Full Text] [Related]
25. Synthesis, biotransformation, and pharmacokinetic studies of 9-(beta-D-arabinofuranosyl)-6-azidopurine: a prodrug for ara-A designed to utilize the azide reduction pathway. Kotra LP; Manouilov KK; Cretton-Scott E; Sommadossi JP; Boudinot FD; Schinazi RF; Chu CK J Med Chem; 1996 Dec; 39(26):5202-7. PubMed ID: 8978848 [TBL] [Abstract][Full Text] [Related]
26. Inactivation of S-adenosylhomocysteine hydrolase by 9-beta-D-arabinofuranosyladenine in intact cells. Helland S; Ueland PM Cancer Res; 1982 Mar; 42(3):1130-6. PubMed ID: 7059972 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and antiviral activity of certain 5'-monophosphates of 9-D-arabinofuranosyladenine and 9-D-arabinofuranosylhypoxanthine. Revankar GR; Huffman JH; Allen LB; Sidwell RW; Robins RK; Tolman RL J Med Chem; 1975 Jul; 18(7):721-6. PubMed ID: 1171242 [TBL] [Abstract][Full Text] [Related]
28. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds. Schinazi RF; Nahmias AJ Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluations of certain 2-halo-2'-substituted derivatives of 9-beta-D-arabinofuranosyladenine. Secrist JA; Shortnacy AT; Montgomery JA J Med Chem; 1988 Feb; 31(2):405-10. PubMed ID: 3339610 [TBL] [Abstract][Full Text] [Related]
30. Identification of metabolites of 9-beta-D-arabinofuranosyl-2-fluoroadenine, an antitumor and antiviral agent. Struck RF; Shortnacy AT; Kirk MC; Thorpe MC; Brockman RW; Hill DL; El Dareer SM; Montgomery JA Biochem Pharmacol; 1982 Jun; 31(11):1975-8. PubMed ID: 7115418 [TBL] [Abstract][Full Text] [Related]
32. Arabinosyl-N6-hydroxyadenine: a new potent antivirus drug. Lopez C; Giner-Sorolla A Ann N Y Acad Sci; 1977 Mar; 284():351-7. PubMed ID: 212981 [TBL] [Abstract][Full Text] [Related]
33. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor. Falcon MG; Jones BR J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039 [TBL] [Abstract][Full Text] [Related]
34. Irreversible inhibition of S-adenosylhomocysteine hydrolase by nucleoside analogs. Chiang PK; Guranowski A; Segall JE Arch Biochem Biophys; 1981 Mar; 207(1):175-84. PubMed ID: 7235718 [No Abstract] [Full Text] [Related]
35. Cytostatic and antiherpesvirus type 1 and 2 activities of 1-beta-D-arabinofuranosylthymine (ara T) prodrugs. Allen LB; Schröder HC; Löbering HG; Maidhof A; Müller WE Chemotherapy; 1987; 33(4):272-7. PubMed ID: 3038479 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and antiviral activities of arabinofuranosyl-5-ethylpyrimidine nucleosides. Selective antiherpes activity of 1-(beta-D-arabinofuranosyl)-5-ethyluracil. Kulikowski T; Zawadzki Z; Shugar D; Descamps J; De Clercq E J Med Chem; 1979 Jun; 22(6):647-53. PubMed ID: 222908 [No Abstract] [Full Text] [Related]
37. Determination of S-adenosylhomocysteine in tissues following pharmacological inhibition of S-adenosylhomocysteine catabolism. Helland S; Ueland PM Adv Exp Med Biol; 1986; 195 Pt B():663-6. PubMed ID: 3490128 [No Abstract] [Full Text] [Related]
38. Synthesis and antiviral evaluation of 6'-substituted aristeromycins: potential mechanism-based inhibitors of S-adenosylhomocysteine hydrolase. Madhavan GV; McGee DP; Rydzewski RM; Boehme R; Martin JC; Prisbe EJ J Med Chem; 1988 Sep; 31(9):1798-804. PubMed ID: 2842505 [TBL] [Abstract][Full Text] [Related]
39. Nucleosides. 129. Synthesis of antiviral nucleosides: 5-alkenyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracils. Watanabe KA; Su TL; Reichman U; Greenberg N; Lopez C; Fox JJ J Med Chem; 1984 Jan; 27(1):91-4. PubMed ID: 6317862 [TBL] [Abstract][Full Text] [Related]
40. [Combined action of nucleosides and alpha-interferon in inhibiting the reproduction of the herpes simplex type-II virus]. Temicheva EV; Malinovskaia VV; Manakhova LS; Mironova LL; Galegov GA Biull Eksp Biol Med; 1987 Oct; 104(10):490-2. PubMed ID: 2823929 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]